Teva Wants Eli Lilly Sanctioned In Migraine Drug Patent Fight
Teva Pharmaceuticals asked a Massachusetts federal court on Wednesday to sanction Eli Lilly and Co. in their battle over patents tied to a migraine biologic, claiming that the rival failed to...To view the full article, register now.
Already a subscriber? Click here to view full article